Severe myasthenia gravis with anti-LRP4 antibodies and Hodgkin lymphoma

被引：1
|
作者：
Hayashi, Naoki [1 ]
Sone, Jun [2 ]
Fukami, Yuki [1 ]
Yoshida, Yusuke [1 ]
Kuno, Shunsuke [3 ]
Shimada, Kazuyuki [3 ]
Atsuta, Naoki [1 ]
Nakamura, Tomohiko [1 ]
Higuchi, Osamu [4 ]
Katsuno, Masahisa [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan
[2] Natl Hosp Org Suzuka Natl Hosp, Dept Neurol, Suzuka, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[4] Nagasaki Kawatana Med Ctr, Dept Clin Res, Nagasaki, Japan
来源：
MUSCLE & NERVE | 2021年 / 63卷 / 01期
关键词：
PROTEIN; 4; AUTOANTIBODIES;
D O I：
10.1002/mus.27079
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E2 / E4
页数：4
相关论文
共 43 条
  • [1] Anti-MuSK Positive Myasthenia Gravis with Anti-Lrp4 and Anti-titin Antibodies
    Yamashita, Rika
    Shimizu, Mikito
    Baba, Kousuke
    Beck, Goichi
    Kinoshita, Makoto
    Okuno, Tatsusada
    Higuchi, Osamu
    Mochizuki, Hideki
    INTERNAL MEDICINE, 2021, 60 (01) : 137 - 140
  • [2] ANTI-LRP4 AUTOANTIBODIES IN CHINESE PATIENTS WITH MYASTHENIA GRAVIS
    Li, Yuan
    Zhang, Yifan
    Cai, Gang
    He, Dian
    Dai, Qingqing
    Xu, Zhu
    Chu, Lan
    MUSCLE & NERVE, 2017, 56 (05) : 938 - 942
  • [3] A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
    Zisimopoulou, P.
    Evangelakou, P.
    Tzartos, J.
    Lazaridis, K.
    Zouvelou, V.
    Mantegazza, R.
    Antozzi, C.
    Andreetta, F.
    Evoli, A.
    Deymeer, F.
    Saruhan-Direskeneli, G.
    Durmus, H.
    Brenner, T.
    Vaknin, A.
    Berrih-Aknin, S.
    Cuvelier, M. Frenkian
    Stojkovic, T.
    DeBaets, M.
    Losen, M.
    Martinez-Martinez, P.
    Kleopa, K. A.
    Zamba-Papanicolaou, E.
    Kyriakides, T.
    Kostera-Pruszczyk, A.
    Szczudlik, P.
    Szyluk, B.
    Lavrnic, D.
    Basta, I.
    Peric, S.
    Tallaksen, C.
    Maniaol, A.
    Tzartos, S. J.
    JOURNAL OF AUTOIMMUNITY, 2014, 52 : 139 - 145
  • [4] Double Seronegative Myasthenia Gravis with Anti-LRP4 Antibodies Presenting with Dropped Head and Acute Respiratory Insufficiency
    Beck, Goichi
    Yabumoto, Taiki
    Baba, Kousuke
    Sasaki, Tsutomu
    Higuchi, Osamu
    Matsuo, Hidenori
    Mochizuki, Hideki
    INTERNAL MEDICINE, 2016, 55 (22) : 3361 - 3363
  • [5] Anti-LRP4 Antibody-associated Myasthenia Gravis with a Rare Complication of Thymoma Successfully Treated by Thymectomy
    Aoki, Sho
    Nagashima, Kazuaki
    Furuta, Minori
    Makioka, Kouki
    Fujita, Yukio
    Saito, Kazuma
    Kashima, Tomoyuki
    Nakajima, Nozomi
    Ikota, Hayato
    Higuchi, Osamu
    Ikeda, Yoshio
    INTERNAL MEDICINE, 2020, 59 (09) : 1219 - 1222
  • [6] Double seronegative myasthenia gravis with anti-LRP 4 antibodies
    Zouvelou, Vasiliki
    Zisimopoulou, Paraskevi
    Rentzos, Michael
    Karandreas, Nikos
    Evangelakou, Panagiota
    Stamboulis, Eleftherios
    Tzartos, Socrates J.
    NEUROMUSCULAR DISORDERS, 2013, 23 (07) : 568 - 570
  • [7] Clinical Characteristics and Prognosis of Anti-AChR Positive Myasthenia Gravis Combined With Anti-LRP4 or Anti-Titin Antibody
    Chen, Yuping
    Tao, Xiaoyong
    Wang, Yan
    Xu, Shengjie
    Yang, Yanhua
    Han, Jinming
    Qiu, Feng
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [8] Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis
    Yan, Min
    Xing, Guang-Lin
    Xiong, Wen-Cheng
    Mei, Lin
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1413 (01) : 126 - 135
  • [9] Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis
    Yu, Zheng
    Zhang, Meiying
    Jing, Hongyang
    Chen, Peng
    Cao, Rangjuan
    Pan, Jinxiu
    Luo, Bin
    Yu, Yue
    Quarles, Brandy M.
    Xiong, Wencheng
    Rivner, Michael H.
    Mei, Lin
    NEUROLOGY, 2021, 97 (10) : E975 - E987
  • [10] Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent
    Bokoliya, Suresh C.
    Kumar, Veeramani Preethish
    Nashi, Saraswati
    Polavarapu, Kiran
    Nalini, Atchayaram
    Patil, Shripad A.
    CLINICA CHIMICA ACTA, 2018, 486 : 34 - 35
12345